NOBEL BIOCARE DANMARK A/S: Financial statements 2022
CVR: 28293364
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,338,235 and a net result of DKK -488,865 compared with DKK 267,699 the year before. That is a decrease of 21.8% compared with the year before. Equity in the 2022 report amounted to DKK 369,246. The solvency ratio was 0.6%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,338,235
- Profit/Loss
- DKK -488,865
- Equity
- DKK 369,246
- Total Assets
- DKK 60,968,984
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.3M | -489K | 369K | 3 |
| 2021 | - | 4.3M | 268K | 858K | 3 |
| 2020 | - | 4.8M | -794K | -1.4M | 5 |
| 2019 | - | 4M | -5.5M | -616K | 4 |
| 2018 | - | 3.3M | 420K | 4.9M | 3 |
Official annual report
Keep an eye on NOBEL BIOCARE DANMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of September 26, 2022, Chris James Stahle has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of September 26, 2022, Lars Fredrik Strömberg has left the board of directors of NOBEL BIOCARE DANMARK A/S.
As of September 26, 2022, Chris James Stahle is registered as adm. dir. of NOBEL BIOCARE DANMARK A/S.
As of September 26, 2022, Lars Fredrik Strömberg has stepped down as director of NOBEL BIOCARE DANMARK A/S.
NOBEL BIOCARE DANMARK A/S has published its annual report for 2021. Gross profit came to DKK 4,267,743, and the net result was DKK 267,699.
As of August 30, 2022, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of NOBEL BIOCARE DANMARK A/S.
As of August 30, 2022, Lars Fredrik Strömberg has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 30, 2022, Magnus Karl Andreas Pettersson has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 30, 2022, Harrieth Eva Elisabeth Sundaeus has joined the board of directors of NOBEL BIOCARE DANMARK A/S.
As of August 30, 2022, Lars Fredrik Strömberg is registered as director of NOBEL BIOCARE DANMARK A/S.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.